Aminoglycoside antibiotics. XII. Effect of N-alkylation in kanamycin antibiotics. 1978

S Nakagawa, and S Toda, and Y Abe, and H Yamashita, and K I Fujisawa, and T Naito, and H Kawaguchi

Four N-ethyl derivatives of kanamycin A and five N-ethyl derivatives of kanamycin B were synthesized. The antimicrobial activity of N-ethyl kanamycin derivatives was determined against aminoglycoside-sensitive and resistant organisms. The structure-activity relationship of these compounds is discussed with reference to the activity of N-acyl kanamycin derivatives.

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000478 Alkylation The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group. Alkylations
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

S Nakagawa, and S Toda, and Y Abe, and H Yamashita, and K I Fujisawa, and T Naito, and H Kawaguchi
April 1979, Journal of medicinal chemistry,
S Nakagawa, and S Toda, and Y Abe, and H Yamashita, and K I Fujisawa, and T Naito, and H Kawaguchi
January 1980, Journal of medicinal chemistry,
S Nakagawa, and S Toda, and Y Abe, and H Yamashita, and K I Fujisawa, and T Naito, and H Kawaguchi
September 1981, The Journal of antibiotics,
S Nakagawa, and S Toda, and Y Abe, and H Yamashita, and K I Fujisawa, and T Naito, and H Kawaguchi
February 1992, The Journal of toxicological sciences,
S Nakagawa, and S Toda, and Y Abe, and H Yamashita, and K I Fujisawa, and T Naito, and H Kawaguchi
September 1974, The Journal of antibiotics,
S Nakagawa, and S Toda, and Y Abe, and H Yamashita, and K I Fujisawa, and T Naito, and H Kawaguchi
January 1981, Journal of hygiene, epidemiology, microbiology, and immunology,
S Nakagawa, and S Toda, and Y Abe, and H Yamashita, and K I Fujisawa, and T Naito, and H Kawaguchi
April 1979, Annales de microbiologie,
S Nakagawa, and S Toda, and Y Abe, and H Yamashita, and K I Fujisawa, and T Naito, and H Kawaguchi
November 1983, The Journal of pharmacology and experimental therapeutics,
S Nakagawa, and S Toda, and Y Abe, and H Yamashita, and K I Fujisawa, and T Naito, and H Kawaguchi
September 1999, Nihon rinsho. Japanese journal of clinical medicine,
S Nakagawa, and S Toda, and Y Abe, and H Yamashita, and K I Fujisawa, and T Naito, and H Kawaguchi
January 2000, Audiology & neuro-otology,
Copied contents to your clipboard!